FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...

Dpcr Market To Surpass US$14.34 Billion By 2031, Propelled By Escalating Demand For High‐Precision Genetic Analysis - New Industry Research By The Insight Partners.. Growing demand for sensitive and ...

Countable Labs, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology. The platform is ideal for any ...

Digital PCR, or dPCR, is a molecular biology technique that detects and quantifies nucleic acid targets. By partitioning a sample into many individual reactions, scientists can measure whether a ...

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...